So sánh phương pháp
Xem các phương pháp đã chọn cạnh nhau; những hàng khác biệt được làm nổi bật.
| Quality-Adjusted Life Year (QALY)× | Phân tích chi phí-hiệu quả (CEA)× | |
|---|---|---|
| Lĩnh vực | Kinh tế học y tế | Kinh tế học y tế |
| Họ | Process / pipeline | Process / pipeline |
| Năm ra đời≠ | 1985 | 1984 |
| Người khởi xướng≠ | Alan Williams (Health Economics Research Centre, Oxford University) | Drummond & Stoddart (Health Economics Research Group, McMaster University) |
| Loại | Method | Method |
| Công trình gốc≠ | Kind, P. (1989). The EuroQol instrument: an index of health-related quality of life. In B. Teeling Smith (Ed.), Measuring health: a practical approach. Chichester: Wiley. link ↗ | Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. New York: Oxford University Press. link ↗ |
| Tên gọi khác≠ | QALY, health utility measure | CEA, ICER, Incremental Cost-Effectiveness Ratio |
| Liên quan | 5 | 5 |
| Tóm tắt≠ | A QALY measures health benefit as utility weight (0 = death, 1 = perfect health) multiplied by time lived. Developed by Alan Williams in 1985, QALYs enable comparison of disparate health interventions on a common metric. Used globally by health technology assessment bodies—NICE (UK), HAS (France), CADTH (Canada), WHO—to decide which treatments deserve public funding. | Cost-effectiveness analysis compares the incremental cost per unit of health benefit gained by one intervention relative to a comparator (standard care or best alternative). Developed rigorously in the 1980s by Drummond, Stoddart, and colleagues, CEA is now the standard framework for technology appraisal globally. NICE, HAS, CADTH, and other health technology assessment bodies use CEA to decide which treatments warrant public funding and at what price. |
| ScholarGateBộ dữ liệu ↗ |
|
|